Upregulation of CD44s in c-sis-transformed Balb/c 3T3 cells by autocrine growth factor mechanisms, including PDGF

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 553-560

  Kogerman, Priit ^a   Sy, Man Sun ^a   Culp, Lloyd A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3T3; CD44s; metastasis; PDGF B; sis

Indexed keywords

GROWTH FACTOR;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; MOUSE; NONHUMAN; ONCOGENE C SIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0030970738     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.3.553     Document Type: Article

References (34)

1. Lesley J, Hyman R and Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271-335, 1993.
2. Naujokas MF, Morin M, Anderson MS, Peterson M and Miller J: The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74: 257-268, 1993.
3. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U and Shaw S: T-cell adhesion induced by proteoslycan-immobilized cytokine MIP-1ß. Nature 361: 79-82, 1993.
4. Weber GF, Ashkar S, Glimcher MJ and Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512, 1996.
5. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G and Aruffo A: CD44 isoforms containing exon V3 are resonsible for the presentation of heparin-binding growth factor. J Cell Biol 128: 687-698, 1995.
6. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haußmann I, Matzku S, Wenzel A, Ponta H and Herrlich P: A new variant of glycoprotein CD44 confers inetastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991.
7. Sy MS, Guo YJ and Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859-866, 1991.
8. Eva A, Robbins K, Andersen PR, Srinivasan A, Tronick SR, Reddy SP, Ellmore N, Galen AT, Lautenberger JA, Papas TS, Westin EH, Wong-Staal F, Gallo RC and Aaronson SA: Cellular genes analogous to retroviral one genes are transcribed in human tumor cells. Nature 195: 116-119, 1982.
9. Graves DT, Owen AJ, Barth RK, Tempst P, Winoto A, Fors L, Hood LE and Antoniadcs HN: Detection of c-sis transcripts and synthesis of PDGF-like protein by human osteosarcoma cells. Science 226: 972-974, 1984.
10. Clarke M, Westin E, Schmidt D, Josephs SF, Ratner L, Wong-Staal F, Gallo RC and Reitz MS Jr: Transformation of NIH-3T3 cells by a human c-sis cDNA clone. Nature 308: 464-467, 1984.
11. Beckmann MP, Betsholtz C, Heldin CH, Wcstermark B, Di Marco E, Di Fiore PP, Robbins KC and Aaronson SA: Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science 241: 1346-1349, 1988.
12. Fleming TP, Matsui T, Molloy CJ, Robbins KC and Aaronson SA: Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors. Proc Natl Acad Sci USA 86: 8063-8067, 1989.
13. Lin W-C, O'Connor KL and Culp LA: Complementation of two related tumor cell classes during experimental metastasis tagged with different histochemical marker genes. BrJ Cancer 67: 910-921, 1993.
14. Kogerman P, Sy M-S and Culp LA: Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with inetastatic capacity. Clin Exp Metastasis 14: 73-82, 1996.
15. Kogerman P, Sy M-S and Culp LA: CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene. J Cell Physiol 169: 341-349, 1996.
16. Lin W-C, Prctlow TP, Pretlow TG and Culp LA: Bacterial lacZ gene a, a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res 50: 2808-2817, 1990.
17. Radinsky R, Kraemer PM, Raines MA, Kung HJ and Culp LA: Amplification and rearrangement of the Kirsten-ras oncogene in virus-transformed Balb/c 3T3 cells during malignant tumor progression. Proc Natl Acad Sci USA 84: 5143-5147, 1987.
18. Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T and Kineade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171: 477-488, 1990.
19. Miyake K, Underhill CB, Lesley J and Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69-75, 1990.
20. Iida H, Seifert R, Alpers CE, Gronwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF and Johnson R: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial prolifcrative nephritis in the rat. Proc Natl Acad Sci USA 88: 6560-6564, 1991.
21. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
22. Guo YJ, Ma J, Wang JH, Lin SC, Chang HC, Bigby M and Sy MS: Hyaluronic acid and anti-CD44 antibodies have distinct effects on the activation of murine T-cell hybridomas and normal T-lymphocytes. Cell Immunol 152: 186-199, 1993.
23. Nottenburg C, Rees G and St John T: Isolation of mouse CD44 cDNA: structural features are distinct from the primate cDNA. Proc Natl Acad Sci USA 86: 8521-8525, 1989.
24. Seppa H, Grotendorst G, Seppa S, Schiffmann E and Martin GR: Platelet-derived crowth factor is chemotactic for fibroblasts. J Cell Biol 92: 584-588, 1982.
25. Keating MT and Williams LT: Processing of the platelet-derived growth factor receptor. J Biol Chem 262: 7932-7937, 1987.
26. Vaziri C and Faller DV: Repression of platelet-derived growth factor ß-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts. Mol Cell Biol 15: 1244-1253, 1995.
27. Bowen-Pope DF, Vogel A and Ross R: Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci USA 81: 2396-2400, 1984.
28. Garrett JS, Coughlin SR, Niman HL, Tremble PM, Giels GM and Williams LT: Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors. Proc Natl Acad Sci USA 81: 7466-7470, 1984.
29. Huang JS, Huang SS and Deuel TF: Transforming protein of Simian Sarcoma Virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell 39: 79-87, 1984.
30. Johnsson A, Betsholtz C, von der Helm K, Heldin CH and Westermark B: Platelet-derived growth factor receptor agonist activity of a secreted form of the v-sis oncogene. Proc Natl Acad Sci USA 82: 1721-1725, 1985.
31. Owen AJ, Pantazis P and Antoniades HN: Simian Sarcoma Virus-transformed cells secrete a mitogen identical to platelet-derived growth factor. Science 225: 54-56, 1984.
32. Robbins KC, Leal F, Pierce JH and Aaronson SA: The v-sis/PDGF-2 transforming gene product localizes to cell mebranes but is not a secretory protein. EMBO J 4: 1783-1792, 1985.
33. LaRochelle WJ, May-Siroff M, Robbins KC and Aaronson SA: A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev 5: 1191-1199, 1991.
34. Testa J: The role of urokinase-type plasminogen activator in aegressive tumor cell behavior. Cancer Metast Rev 9: 353-367, 1990.